Magle Chemoswed Holding AB Sustainability Reports
Magle Chemoswed Holding AB operates as a contract development and manufacturing organization (CDMO) that serves the pharmaceutical and medical device industries. The enterprise develops and manufactures healthcare innovations based on degradable starch microspheres, regenerative technologies, and dextran derivatives.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300FNJZS6NGFB6M31
FIGI: BBG00VLFKHX8
1 reports from 2024 to 2024
